๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of small intestinal fistulas with octreotide, a somatostatin analog

โœ Scribed by Guy M. Boike; Sterling E. Sightler; Hervy E. Averette


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
286 KB
Volume
49
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Three patients with external small bowel fistulas were successfully treated with bowel rest, total parenteral nutrition, and the somatostatin analog, octreotide. Two of the patients had received prior multimodality therapy, including radiation, for gynecologic cancer. The time intervals to fistula closure were 2 days, 10 days, and 5 weeks after initiation of octreotide therapy. The efficacy of octreotide combined with total parenteral nutrition in the treatment of external enteric fistulas supports its routine use, especially in previously irradiated patients.


๐Ÿ“œ SIMILAR VOLUMES


Somatostatin analog treatment of a cervi
โœ Carl N. Valentine; Roberto Barresi; Richard A. Prinz ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB

## Abstract ## Background Reoperation for recurrent thyroid cancer poses an increased risk of complications, including thoracic duct fistula. Treatment of this complication is controversial. A survey of thoracic literature reports the use of somatostatin analog, whereas no cases have reported the

A phase III evaluation of a somatostatin
โœ David L. Morris ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 3 views

I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o